GBA1 and Gaucher disease: Additionally, GCS inhibitors, such as eliglustat, are a clinically available treatment option for Gaucher disease, a rare inherited metabolic disorder in which deficiency of the enzyme glucocerebrosidase results in lysosomal accumulation of glucocerebrosides45.